BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8962240)

  • 1. Inhibitory CD94 molecules identified by the Z199 monoclonal antibody recognize different HLA-class I molecules.
    Sivori S; Vitale M; Sanseverino L; Parolini S; Barbaresi M; Bottino C; Moretta A
    Transplant Proc; 1996 Dec; 28(6):3199-203. PubMed ID: 8962240
    [No Abstract]   [Full Text] [Related]  

  • 2. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies.
    Sivori S; Vitale M; Bottino C; Marcenaro E; Sanseverino L; Parolini S; Moretta L; Moretta A
    Eur J Immunol; 1996 Oct; 26(10):2487-92. PubMed ID: 8898964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules.
    Carretero M; Cantoni C; Bellón T; Bottino C; Biassoni R; Rodríguez A; Pérez-Villar JJ; Moretta L; Moretta A; López-Botet M
    Eur J Immunol; 1997 Feb; 27(2):563-7. PubMed ID: 9045931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell-mediated recognition of human trophoblast.
    Biassoni R; Bottino C; Millo R; Moretta L; Moretta A
    Semin Cancer Biol; 1999 Feb; 9(1):13-8. PubMed ID: 10092546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
    J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor.
    Pérez-Villar JJ; Carretero M; Navarro F; Melero I; Rodríguez A; Bottino C; Moretta A; López-Botet M
    J Immunol; 1996 Dec; 157(12):5367-74. PubMed ID: 8955184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of the CD94 receptor complex in costimulation of human natural killer cells.
    Voss SD; Daley J; Ritz J; Robertson MJ
    J Immunol; 1998 Feb; 160(4):1618-26. PubMed ID: 9469418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer clones recognize specific soluble HLA class I molecules.
    Carbone E; Terrazzano G; Colonna M; Tuosto L; Piccolella E; Franksson L; Palazzolo G; Pérez-Villar JJ; Fontana S; Kärre K; Zappacosta S
    Eur J Immunol; 1996 Mar; 26(3):683-9. PubMed ID: 8605938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal sequences stop killer cells.
    Long EO
    Nature; 1998 Feb; 391(6669):740-1, 743. PubMed ID: 9486638
    [No Abstract]   [Full Text] [Related]  

  • 14. [CD94/NKG2A--a kind of inhibitory receptor belonging to C-type lectin superfamily].
    Wang Y; Zhu LP; Zhang W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):653-5. PubMed ID: 12905700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do NK cells sense the expression of HLA-G class Ib molecules?
    López-Botet M; Navarro F; Llano M
    Semin Cancer Biol; 1999 Feb; 9(1):19-26. PubMed ID: 10092547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
    Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
    J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
    Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
    Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
    King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM
    Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49.
    Toyama-Sorimachi N; Taguchi Y; Yagita H; Kitamura F; Kawasaki A; Koyasu S; Karasuyama H
    J Immunol; 2001 Mar; 166(6):3771-9. PubMed ID: 11238619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.